The Canadian Children Inflammatory Bowel Disease Network (CIDsCaNN)

NCT02308917 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2400

Last updated 2024-03-20

No results posted yet for this study

Summary

The CIDsCaNN Network is being established with the major goals of identifying why IBD develops so commonly in children and adolescents living in Canada, and of determining the best treatment strategies for different types of IBD. Focusing on a prospective, inception cohort of Canadian children of widely varied racial origins provides a unique opportunity to explore environmental risk factors early in life and close in time to disease onset, their influence on the host microbiome, and in the context of genetic susceptibility. In keeping with current treatment targets, assessed outcomes will include not only symptom resolution and growth, but also intestinal healing. We aim to identify best practice and to institute processes for continual improvement in care nationally.

Conditions

Sponsors & Collaborators

  • Children's Hospital of Eastern Ontario

    collaborator OTHER
  • British Columbia Children's Hospital

    collaborator OTHER
  • Alberta Children's Hospital

    collaborator OTHER
  • Stollery Children's Hospital

    collaborator OTHER
  • IWK Health Centre

    collaborator OTHER
  • Montreal Children's Hospital of the MUHC

    collaborator OTHER
  • St. Justine's Hospital

    collaborator OTHER
  • Health Sciences Centre, Winnipeg, Manitoba

    collaborator OTHER
  • Eastern Health

    collaborator OTHER
  • Children's Hospital of Western Ontario

    collaborator OTHER
  • McMaster Children's Hospital

    collaborator OTHER
  • The Hospital for Sick Children

    lead OTHER

Principal Investigators

  • Anne M Griffiths, MD, FRCPC · The Hospital for Sick Children

Eligibility

Min Age
2 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2026-04-01
Completion
2026-04-01

Countries

  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02308917 on ClinicalTrials.gov